Terminal osseous dysplasia with pigmentary defects (TODPD) due to a recurrent filamin A (FLNA) mutation
- PMID: 25614868
- PMCID: PMC4303216
- DOI: 10.1002/mgg3.90
Terminal osseous dysplasia with pigmentary defects (TODPD) due to a recurrent filamin A (FLNA) mutation
Abstract
Terminal osseous dysplasia with pigmentary defects (TODPD) is an X-linked dominant syndrome with distal limb anomalies, pigmentary skin defects, digital fibromas, and generalized bone involvement due to a recurrent mutation in the filamin A (FLNA) gene. We here report the mutation c.5217G>A in FLNA in three families with TODPD and we found possible germline and somatic mosaicism in two out of the three families. The occurrence of somatic and germline mosaicism for TODPD indicates that caution should be taken in counseling recurrence risks for these conditions upon presentation of an isolated case.
Keywords: FLNA; Filamin A; X-linked dominant; terminal osseous dysplasia with pigmentary defects.
Figures
References
-
- Bacino CA, Stockton DW, Sierra RA, Heilstedt HA, Lewandowski R. Van den Veyver IB. Terminal osseous dysplasia and pigmentary defects: clinical characterization of a novel male lethal X-linked syndrome. Am. J. Med. Genet. 2000;94:102–112. - PubMed
-
- Brunetti-Pierri N, Lachman R, Lee K, Leal SM, Piccolo P, Van Den Veyver IB, et al. Terminal osseous dysplasia with pigmentary defects (TODPD): follow-up of the first reported family, characterization of the radiological phenotype, and refinement of the linkage region. Am. J. Med. Genet. A. 2010;152A:1825–1831. - PMC - PubMed
-
- Clark AR, Sawyer GM, Robertson SP. Sutherland-Smith AJ. Skeletal dysplasias due to filamin A mutations result from a gain-of-function mechanism distinct from allelic neurological disorders. Hum. Mol. Genet. 2009;18:4791–4800. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
